1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Colorado >
  6. Inscripta Acquires Infinome Biosciences

M&A Deal Summary

Inscripta Acquires Infinome Biosciences

On January 18, 2023, Inscripta acquired life science company Infinome Biosciences

Acquisition Highlights
  • This is Inscripta’s 1st transaction in the Life Science sector.
  • This is Inscripta’s 2nd transaction in the United States.
  • This is Inscripta’s 1st transaction in Colorado.

M&A Deal Summary
Date 2023-01-18
Target Infinome Biosciences
Sector Life Science
Buyer(s) Inscripta
Deal Type Add-on Acquisition

Target

Infinome Biosciences

Boulder, Colorado, United States
Infinome Biosciences is a bioengineering company dedicated to unlocking the infinite potential of the genome. Infinome Biosciences is based in Boulder, Colorado.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Inscripta

Boulder, Colorado, United States
Category Company
Sector Life Science
DESCRIPTION

Inscripta is a life science technology company enable scientists to bolster and expand domestic biomanufacturing, and spur new, safe, and secure biotech innovations. Inscripta is based in Boulder, Colorado.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 2 of 2
State: Colorado M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2023 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-01-18 Sestina Bio

Pleasanton, California, United States

Sestina Bio is a new platform for data-driven synthetic biology. Sestina Bio is based in Pleasanton, California.

Buy -
Mergr

Solution for

Product

Company

Legal